A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus–infected patients awaiting liver transplantation

Decompensated liver disease associated with chronic hepatitis C virus (HCV) infection is the most common indication for liver transplantation. It was shown previously that greater pretransplantation HCV titers are associated with relatively poor patient and graft survival. The tolerability and effic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Liver transplantation 2002-04, Vol.8 (4), p.350-355
Hauptverfasser:	Crippin, Jeffrey S., McCashland, Tim, Terrault, Norah, Sheiner, Patricia, Charlton, Michael R.
Format:	Artikel
Sprache:	eng
Schlagworte:	alpha -Interferon Antiviral Agents - adverse effects Antiviral Agents - therapeutic use beta -Interferon Chronic infection Cirrhosis Drug Administration Schedule Drug Therapy, Combination Female Genotype Hepacivirus - genetics Hepacivirus - isolation & purification Hepatitis C Hepatitis C - drug therapy Hepatitis C virus Humans Interferon Interferon-alpha - adverse effects Interferon-alpha - therapeutic use Leukopenia Liver diseases Liver transplantation Liver Transplantation - physiology Male Middle Aged Patient Selection Pilot Projects Probability Recombinant Proteins Ribavirin Ribavirin - adverse effects Ribavirin - therapeutic use RNA RNA, Viral - blood Safety Survival Thrombocytopenia Viral Load Waiting Lists
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!